Altered resting state functional brain network topology in chemotherapy-treated breast cancer survivors

Neurobiology of Disease

Volumn 48, Issue 3, 2012, Pages 329-338

  Bruno, Jennifer ^a   Hosseini, S M Hadi ^a   Kesler, Shelli ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD CANCER INSTITUTE   (United States)

Author keywords

Brain; Breast cancer; Chemotherapy; Cognition; Connectome; Graph theory; Resting state fMRI

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; PACLITAXEL; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVOR; COGNITIVE DEFECT; CONTROLLED STUDY; EXECUTIVE FUNCTION; FEMALE; FRONTAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MAJOR CLINICAL STUDY; MEMORY DISORDER; MENTAL TEST; NERVE CELL NETWORK; NEUROBIOLOGY; PRIORITY JOURNAL; REST; SELF REPORT; STRIATE CORTEX; TEMPORAL CORTEX; THEORETICAL STUDY; WHOLE BODY SCANNER;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BRAIN; BREAST NEOPLASMS; COGNITION DISORDERS; CONNECTOME; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEURAL PATHWAYS; NEUROPSYCHOLOGICAL TESTS; SURVIVORS;

EID: 84864800690     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2012.07.009     Document Type: Article

References (77)

1. Achard S., Bullmore E. Efficiency and cost of economical brain functional networks. PLoS Comput. Biol. 2007, 3:e17.
2. Ahles T.A., Saykin A.J., et al. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J. Clin. Oncol. 2010, 28:4434-4440.
3. Bakkum-Gamez J.N., Laughlin S.K., et al. Challenges in the gynecologic care of premenopausal women with breast cancer. Mayo Clin. Proc. 2011, 86:229-240.
4. Bassett D.S., Bullmore E. Small-world brain networks. Neuroscientist 2006, 12:512-523.
5. Bassett D.S., Bullmore E., et al. Hierarchical organization of human cortical networks in health and schizophrenia. J. Neurosci. 2008, 28:9239-9248.
6. Behzadi Y., Restom K., et al. A component based noise correction method (CompCor) for BOLD and perfusion based fMRI. Neuroimage 2007, 37:90-101.
7. Bernhardt B.C., Chen Z., et al. Graph-theoretical analysis reveals disrupted small-world organization of cortical thickness correlation networks in temporal lobe epilepsy. Cereb. Cortex 2011, 21:2147-2157.
8. Bracken B.A., Howell K. Test review: clinical assessment of depression 2007, Psychological Assessment Resources, Odessa Fl.
9. Bullmore E.T., Bassett D.S. Brain graphs: graphical models of the human brain connectome. Annu. Rev. Clin. Psychol. 2011, 7:113-140.
10. Bullmore E., Sporns O. Complex brain networks: graph theoretical analysis of structural and functional systems. Nat. Rev. Neurosci. 2009, 10:186-198.
11. Castellon S., Ganz P.A. Neuropsychological studies in breast cancer: in search of chemobrain. Breast Cancer Res. Treat. 2009, 116:125-127.
12. Chen G., Ward B.D., et al. Classification of Alzheimer disease, mild cognitive impairment, and normal cognitive status with large-scale network analysis based on resting-state functional MR imaging. Radiology 2011, 259:213-221.
13. Chen Z.J., He Y., et al. Age-related alterations in the modular organization of structural cortical network by using cortical thickness from MRI. Neuroimage 2011, 56:235-245.
14. Church J.A., Fair D.A., et al. Control networks in paediatric Tourette syndrome show immature and anomalous patterns of functional connectivity. Brain 2009, 132:225-238.
15. Cimprich B., Reuter-Lorenz P., et al. Prechemotherapy alterations in brain function in women with breast cancer. J. Clin. Exp. Neuropsychol. 2010, 32:324-331.
16. Correa D.D., Shi W., et al. Cognitive functions in primary CNS lymphoma after single or combined modality regimens. Neuro Oncol. 2012, 14:101-108.
17. de Ruiter M.B., Reneman L., et al. Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Hum. Brain Mapp. 2011, 32:1206-1219.
18. Delis D., Kaplan E., et al. Delis-Kaplan Executive Function System 2001, Psychological Corporation, New York.
19. Deprez S., Amant F., et al. Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Hum. Brain Mapp. 2011, 32:480-493.
20. Deprez S., Amant F., et al. Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. J. Clin. Oncol. 2012, 30:274-281.
21. Dietrich J. Chemotherapy associated central nervous system damage. Adv. Exp. Med. Biol. 2010, 678:77-85.
22. Dietrich J., Han R., et al. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J. Biol. 2006, 5:22.
23. Du X.L., Xia R., et al. Relationship between chemotherapy use and cognitive impairments in older women with breast cancer: findings from a large population-based cohort. Am. J. Clin. Oncol. 2010, 33:533-543.
24. Ferguson R.J., McDonald B.C., et al. Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy. J. Clin. Oncol. 2007, 25:3866-3870.
25. Glover G.H., Lai S. Self-navigated spiral fMRI: interleaved versus single-shot. Magn. Reson. Med. 1998, 39:361-368.
26. Gong G., Rosa-Neto P., et al. Age- and gender-related differences in the cortical anatomical network. J. Neurosci. 2009, 29:15684-15693.
27. Guye M., Bettus G., et al. Graph theoretical analysis of structural and functional connectivity MRI in normal and pathological brain networks. MAGMA 2010, 23:409-421.
28. He Y., Chen Z., et al. Structural insights into aberrant topological patterns of large-scale cortical networks in Alzheimer's disease. J. Neurosci. 2008, 28:4756-4766.
29. Heaton R. Wisconsin Card Sorting Test Computer Version 4 [WCST: CV4] 2004, Psychological Assessment Resources, Odessa FL.
30. Humphries M., Gurney K., et al. The brainstem reticular formation is a small-world, not scale-free, network. Proc. R. Soc. Biol. Sci. 2006, 273:503-511.
31. Inagaki M., Yoshikawa E., et al. Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer 2007, 109:146-156.
32. Janelsins M.C., Roscoe J.A., et al. IGF-1 partially restores chemotherapy-induced reductions in neural cell proliferation in adult C57BL/6 mice. Cancer Invest. 2010, 28:544-553.
33. Janelsins M.C., Kohli S., et al. An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin. Oncol. 2011, 38:431-438.
34. Kaiser M., Hilgetag C.C. Nonoptimal component placement, but short processing paths, due to long-distance projections in neural systems. PLoS Comput. Biol. 2006, 2:e95.
35. Kesler S.R., Bennett F.C., et al. Regional brain activation during verbal declarative memory in metastatic breast cancer. Clin. Cancer Res. 2009, 15:6665-6673.
36. Kesler S.R., Kent J.S., et al. Prefrontal cortex and executive function impairments in primary breast cancer. Arch. Neurol. 2011, 68:1447-1453.
37. Leistedt S.J., Coumans N., et al. Altered sleep brain functional connectivity in acutely depressed patients. Hum. Brain Mapp. 2009, 30:2207-2219.
38. Lynall M.E., Bassett D.S., et al. Functional connectivity and brain networks in schizophrenia. J. Neurosci. 2010, 30:9477-9487.
39. Maes M., Mihaylova I., et al. Activation of cell-mediated immunity in depression: association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 36:169-175.
40. Mar Fan H., Houédé-Tchen N., et al. Menopausal symptoms in women undergoing chemotherapy-induced and natural menopause: a prospective controlled study. Ann. Oncol. 2010, 21:983-987.
41. Maslov S., Sneppen K. Specificity and stability in topology of protein networks. Science 2002, 296:910-913.
42. McDonald B.C., Conroy S.K., et al. Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Res. Treat. 2010, 123:819-828.
43. McIntosh A.R. Towards a network theory of cognition. Neural Netw. 2000, 13:861-870.
44. Milo R., Shen-Orr S., et al. Network motifs: simple building blocks of complex networks. Science 2002, 298:824-827.
45. Nakamura T., Hillary F.G., et al. Resting network plasticity following brain injury. PLoS One 2009, 4:e8220.
46. Petrella J.R. Use of graph theory to evaluate brain networks: a clinical tool for a small world?. Radiology 2011, 259:317-320.
47. Roth R.M., Isquith P.K., et al. Behavioral Rating Inventory of Executive Function - Adult Version 2005, Psychological Assessment Resources, Lutz FL.
48. Rubinov M., Sporns O. Complex network measures of brain connectivity: uses and interpretations. Neuroimage 2010, 52(3):1059-1069.
49. Rubinov M., Sporns O. Complex network measures of brain connectivity: uses and interpretations. Neuroimage 2010, 52:1059-1069.
50. Sanz-Arigita E.J., Schoonheim M.M., et al. Loss of 'small-world' networks in Alzheimer's disease: graph analysis of FMRI resting-state functional connectivity. PLoS One 2010, 5:e13788.
51. Sardi F., Fassina L., et al. Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly. Autoimmun. Rev. 2011, 11(2):149-153.
52. Schagen S.B., Muller M.J., et al. Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. J. Natl. Cancer Inst. 2006, 98:1742-1745.
53. Seigers R., Schagen S.B., et al. Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat. Behav. Brain Res. 2008, 186:168-175.
54. Seigers R., Schagen S.B., et al. Methotrexate decreases hippocampal cell proliferation and induces memory deficits in rats. Behav. Brain Res. 2009, 201:279-284.
55. Sheline Y.I., Morris J.C., et al. APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Abeta42. J. Neurosci. 2010, 30:17035-17040.
56. Silverman D.H., Dy C.J., et al. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10years after chemotherapy. Breast Cancer Res. Treat. 2007, 103:303-311.
57. Sporns O. The human connectome: a complex network. Ann. N. Y. Acad. Sci. 2011, 1224:109-125.
58. Sporns O., Chialvo D.R., et al. Organization, development and function of complex brain networks. Trends Cogn. Sci. 2004, 8:418-425.
59. Stewart A., Collins B., et al. The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study. Psychooncology 2008, 17:122-130.
60. Supekar K., Menon V., et al. Network analysis of intrinsic functional brain connectivity in Alzheimer's disease. PLoS Comput. Biol. 2008, 4:e1000100.
61. Syrjala K.L., Artherholt S.B., et al. Prospective neurocognitive function over 5years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5years. J. Clin. Oncol. 2011, 29:2397-2404.
62. Tian L., Wang J., et al. Hemisphere- and gender-related differences in small-world brain networks: a resting-state functional MRI study. Neuroimage 2011, 54:191-202.
63. Troyer A.K., Rich J.B. Psychometric properties of a new metamemory questionnaire for older adults. J. Gerontol. B Psychol. Sci. Soc. Sci. 2002, 57:P19-P27.
64. Tzourio-Mazoyer N., Landeau B., et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002, 15:273-289.
65. van Wijk B.C., Stam C.J., et al. Comparing brain networks of different size and connectivity density using graph theory. PLoS One 2010, 5:e13701.
66. Vardy J. Cognitive function in breast cancer survivors. Cancer Treat. Res. 2009, 151:387-419.
67. Wang J., Wang L., et al. Parcellation-dependent small-world brain functional networks: a resting-state fMRI study. Hum. Brain Mapp. 2009, 30:1511-1523.
68. Wang L., Zhu C., et al. Altered small-world brain functional networks in children with attention-deficit/hyperactivity disorder. Hum. Brain Mapp. 2009, 30:638-649.
69. Wang J., Zuo X., et al. Graph-based network analysis of resting-state functional MRI. Front. Syst. Neurosci. 2010, 4:16.
70. Wechsler D. Wechsler Adult Intelligence Scale 2008, The Psychological Corporation, San Antonio, TX. Fourth edition.
71. Wefel J.S., Saleeba A.K., et al. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer 2010, 116:3348-3356.
72. Wefel J.S., Vardy J., et al. International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol. 2011, 12:703-708.
73. White T. Neuropsychological Assessment Battery 2003, Psychological Assessment Resources, Inc., Lutz FL.
74. Winocur G., Vardy J., et al. The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice. Pharmacol. Biochem. Behav. 2006, 85:66-75.
75. Wu K., Taki Y., et al. Age-related changes in topological organization of structural brain networks in healthy individuals. Hum. Brain Mapp. 2011, 33:552-568.
76. Zalesky A., Fornito A., et al. Whole-brain anatomical networks: does the choice of nodes matter?. Neuroimage 2010, 50:970-983.
77. Zhang J., Wang J., et al. Disrupted brain connectivity networks in drug-naive, first-episode major depressive disorder. Biol. Psychiatry 2011, 70:334-342.